About
At AposHealth®, we are passionate about revolutionising the treatment of musculoskeletal conditions simply, by addressing peoples’ gait to help them move better, live better, and alleviate pain. Our flagship solution, Apos®, is CE-marked and FDA-cleared foot-worn medical device, aimed at reducing knee pain caused by osteoarthritis and has been used by over 120,000 patients. AposHealth has been demonstrated to reduce the need for joint replacement surgery and can be administered via remote care.
It can also be used as a general wellness device to help patients live well with chronic lower back and hip pain. With a 96% satisfaction rate and over 40 peer-reviewed clinical studies, this system; consisting of gait analysis, personalised foot-worn device, and a customised treatment plan, has helped patients worldwide move, live, and thrive.
Key Facts
86% patients delay surgery 98% patients would recommend Patients report a 70% reduction in pain 96% patient satisfaction rate
Successes in UK/NHS
AposHealth is currently used in three NHS organisations: NHS Bedfordshire, NHS Greenwich, NHS Mid Essex It is also used across a network of 12 clinics that serve the self-pay and private medical insurance marketCompany details
Solutions
Delivering advanced patient care
Specialism
Digitally-enabled out of hospital care
Long-term condition monitoring
Company details
Want to connect with this innovator?
Make an enquiryWebsite
www.aposhealth.co.ukMarkets already exporting to
USA, China
Desired Markets
Europe, Brazil, Middle East
Desired customer types
Depending on the health system and point of entry, all would apply: hospitals, private groups - ideally government health systems given that AposHealth has the ability to impact a large cohort of patients and the burden on joint replacement surgery.